Tenders

Antithrombotic drugs, hemostatic drugs, cardiovascular system drugs, all other therapeutic agents, other hematological agents

Open
Deadline
20 days left
March 23, 2026
Contract Details
Category
Supplies
Reference
304124
Value
€2,800,000
Location
Estonia
Published
February 18, 2026
CPV Code
Evaluation Criteria
Total cost of drug with active ingredient sodium heparin100%
Total cost of drug with active ingredient sodium enoxaparin100%
Total cost of drug with active ingredient tirofiban100%
Total cost of drug with active ingredient alteplase100%
Total cost of drug with active ingredient tenecteplase100%
Total cost of drug with active ingredient rivaroxaban100%
Total cost of drug with active ingredient apixaban100%
Total cost of drug with active ingredient edoxaban100%
Total cost of drug with active ingredient fondaparinux sodium100%
Total cost of drug with active ingredient tranexamic acid100%
Total cost of drug with active ingredient levosimendan100%
Total cost of drug with active ingredient adenosine100%
Project Timeline

Tender Published

February 18, 2026

Deadline for Questions

March 16, 2026

Submission Deadline

March 23, 2026

Tender Opening

March 23, 2026

Win ProbabilityPRO
🔒
Upgrade to Professional
See your estimated win probability based on historical data.
Upgrade to Professional →
Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →
Sector InsightsPRO
🔒
Unlock Sector Insights
See average winning prices, competition levels, and market trends.
Upgrade to Professional →
Budget
€2,800,000
Duration
Not specified
Location
Estonia
Type
Supplies
80
Quality Score/100
Excellent
Market Benchmark
Avg. Winning Price
€92,792
Avg. Bids
2.2
Competition
Low
SME Winners
86%
3,220 tenders analyzed

Original Tender Description

For the purchase of antithrombotic drugs, hemostatic drugs, cardiovascular system drugs, all other therapeutic agents, other hematological agents
Electronic Submission

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

9 requirements across 5 categories

Submission (4)
Mandatory (1)
Compliance (1)
Technical (2)
Financial (1)
SUBMISSION REQUIREMENTS4
--Submit a completed application form confirming review of tender documents, agreement to conditions, and validity of the offer.
--Submit a completed table with the technical proposal including unit prices and total costs for active ingredients, dosage forms, and quantities.
--If joint bidders, submit a power of attorney.
MANDATORY EXCLUSION GROUNDS1
--Do not involve subcontractors or suppliers linked to the Russian Federation by more than 10%.
ELIGIBILITY REQUIREMENTS1
--Agree to the terms and conditions of the draft framework agreement.
TECHNICAL CAPABILITY REQUIREMENTS2
--Offer medicines meeting technical specifications (active ingredients, dosage forms, quantities).
--Ability to offer equivalent products that meet the criteria.
FINANCIAL REQUIREMENTS1
--The bid price must include the total cost for each drug component (sodium heparin, enoxaparin, tirofiban) excluding taxes.

Requirements Preview

Sign up to view complete requirements and analysis

Documents

7 documents available with AI summaries

VastavustingimusedPDF
304124_vastavustingimused.pdf -- 305.6 KB

This document outlines the tender submission conditions, including the requirement not to involve subcontractors or suppliers linked to the Russian Federation beyond 10%, the procedure for submitting a power of attorney for joint bidders, and rules for marking business secrets.

Pakkuja esitab täidetud hankemenetluses osalemise avalduseDOC
304124 Hankemenetluses osalemise avaldus.docx -- 50.8 KB

Bidders must submit a completed application confirming their review of tender documents, agreement to terms, and the validity of their offer.

Pakkuja esitab täidetud tabeli "304124 Tehniline ettepanek ühikuhinnad"XLS
304124 Tehniline ettepanek ühikuhinnad.xlsx -- 37.5 KB

Bidders must submit a completed table detailing their technical proposal for unit prices and total costs of medicines, including active substances, drug forms, and quantities.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
304124_hindamiskriteeriumid.pdf -- 88.1 KB

This document outlines the evaluation criteria for the tender, specifying that bids will be assessed solely on the total cost of each drug part (sodium heparin, enoxaparin, tirofiban) without taxes, with the lowest price receiving maximum points.

Hankepass täiendatavate selgitustegaPDF
304124_hankepass_taiendavate_selgitustega.pdf -- 75.6 KB

This ESPD document is an explanatory guide outlining the contracting authority's conditions and expected qualification requirements for bidders, but it is not to be submitted as a filled form.

Lepingu projektDOC
304124 Apteegikauba riigihanke raamleping.doc... -- 55.2 KB

This is a draft framework agreement for the public procurement of pharmaceutical goods, detailing the terms and conditions for the supply of medicines to buyers, including SA Põhja-Eesti Regionaalhaigla.

Tehniline kirjeldusXLS
304124 Tehniline kirjeldus.xlsx -- 27.7 KB

This document specifies the technical requirements for the medicines to be procured, listing specific active substances, pharmaceutical forms, and quantities that the contracting authority intends to purchase, emphasizing the acceptance of equivalents.

Documents Preview

Sign up to view document summaries and analysis

80
Excellent

Tender Quality Score

This public procurement is well-structured and transparent, particularly regarding evaluation criteria, but it has shortcomings in contract duration and sustainability aspects. The tender demonstrates good compliance with legal frameworks and promotes fair competition.

Score Breakdown

Legal Compliance85/100

The tender generally complies with legal requirements, including the presence of an ESPD and specific exclusion grounds related to the Russian Federation, indicating adherence to current geopolitical regulations. The procedure type and CPV codes are clearly defined.

Clarity90/100

The tender's description, requirements, and evaluation criteria are exceptionally clear and unambiguous. The technical specifications accept equivalents, and the evaluation is solely based on the lowest price, ensuring transparency.

Completeness75/100

Basic information, financial details, and key deadlines are provided. However, the explicit contract duration beyond the tender validity and a specific NUTS code or delivery location are not clearly stated, which are notable omissions for a procurement of physical goods.

Missing explicit contract duration beyond tender validity.
Missing specific delivery/service location (NUTS code empty).
Fairness95/100

The tender exhibits high fairness due to objective, lowest-price-based evaluation criteria and the explicit acceptance of equivalent products in technical specifications. Electronic submission ensures equal access, and the value is fully disclosed.

Practicality70/100

Electronic submission and e-procurement are supported, enhancing practicality. However, the absence of a clear contract start date and the precise contract duration (beyond tender validity) could pose minor planning challenges for potential bidders.

Missing explicit contract start date.
Missing explicit contract duration.
Data Consistency85/100

The data provided is largely consistent and logical, with dates aligning correctly. Minor inconsistencies include the empty NUTS code field and the lack of explicit contract duration, but these do not indicate major data integrity issues.

NUTS code field is empty.
Contract duration is not explicitly stated.
Sustainability40/100

The tender does not explicitly incorporate green, social, or innovation procurement criteria. While the exclusion ground related to the Russian Federation has ethical implications, it does not align with typical sustainability metrics in procurement.

No explicit green procurement criteria.
No explicit social criteria.

Strengths

Clear and objective evaluation criteria (lowest price).
Comprehensive documentation with acceptance of equivalent products.
Electronic submission and e-procurement enabled.
Transparency in estimated value and tender details.
Compliance with geopolitical exclusion grounds (Russian Federation links).

Concerns

Missing explicit contract duration beyond tender validity.
Lack of specific delivery/service location (NUTS code empty).
Absence of explicit green, social, or innovation procurement criteria.
Contract start date not explicitly stated.

Recommendations

1. Specify the expected contract duration and start date within the tender documents.
2. Include the NUTS code and clarify delivery locations for the medicines.
3. Consider integrating sustainability criteria (e.g., packaging, supply chain ethics) in future tenders, where applicable.

AI Scoring Preview

Sign up to view complete requirements and analysis

Complete quality score analysis
Detailed sub-score breakdown
Strengths & concerns insights
Strategic recommendations

No credit card required • Setup in 2 minutes

Add to Pipeline